Will Morgan Stanley's Q2 2026 Investment Banking revenue grow at least 15% year over year?

Q1 2026 IB at $2.1B (+20-31% YoY); 15% threshold implies $2.24B for Q2 — only 7% above Q1's run-rate. Advisory cycle typically sustains 2-3 quarters once ignited (+74% Q1 advisory). Q2 2025 base of $1.95B is harder than Q1 2025's $1.6-1.75B, which compresses YoY math by ~10 pts. Lean YES at 58%.

Tail risks: geopolitical Middle East conflict named explicitly by Pick as 'known unknown' typically slows IB activity; Asia 45% of QoQ improvement = concentration risk if regional policy shifts; advisory +74% Q1 may have been pent-up backlog flush. Modest YES.

Pick's 'third inning' framing + concrete pipeline commentary + record FI underwriting backlog + IPO/convertibles calendar robust + MUFG JV/India re-equitization momentum. Q2 needs $2.24B vs Q1's $2.1B — a 7% sequential lift that ISG records suggest is achievable. Slight YES tilt at 60%.

Capital markets cycle continuation rate when Q1 IB grows 20%+ YoY: ~55-65% historical sustain rate. Apply slight discount for Q2 2025 harder comp. Around 56%.

Pipeline commentary supports but consensus often overestimates IB growth at cycle peaks. The 15% bar is more achievable than Q1's 20% but Q2 base is harder. Flat-to-slight YES.

Coin-flip leaning YES. Advisory pop is hard to repeat at +74% pace; even moderate deceleration (advisory at +40-50%) plus equity/FI underwriting flat would put Q2 IB near $2.0-2.1B and miss 15%.

Strong Q1 IB momentum; pipeline steady; 15% threshold lower than Q1's 20%. Lean YES.

Cycle on, 15% achievable. But advisory deceleration risk. Moderate YES at 58%.

Q2 base harder, 15% bar reasonable. Lean YES at 55%.